Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043334
Filing Date
2025-05-14
Accepted
2025-05-14 16:20:46
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241832-10q_china.htm   iXBRL 10-Q 475612
2 THE THIRD AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY ea024183201ex3-1_china.htm EX-3.1 24293
3 CERTIFICATION ea024183201ex31-1_china.htm EX-31.1 9810
4 CERTIFICATION ea024183201ex31-2_china.htm EX-31.2 9976
5 CERTIFICATION ea024183201ex32-1_china.htm EX-32.1 5464
  Complete submission text file 0001213900-25-043334.txt   4122531

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cphi-20250331.xsd EX-101.SCH 38546
7 XBRL CALCULATION FILE cphi-20250331_cal.xml EX-101.CAL 41965
8 XBRL DEFINITION FILE cphi-20250331_def.xml EX-101.DEF 194601
9 XBRL LABEL FILE cphi-20250331_lab.xml EX-101.LAB 348368
10 XBRL PRESENTATION FILE cphi-20250331_pre.xml EX-101.PRE 205543
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0241832-10q_china_htm.xml XML 330492
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 25946014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)